source
- Dr Postow on the Timing of Delayed or Re-Emergent irAEs in MelanomaMichael A. Postow, MD, discusses the evolving understanding of ICIs in melanoma and the unique toxicity profiles associated with these agents.onclive · 3mo ago↗ source
- Temple Health’s Fox Chase Cancer Center and Labcorp Collaborate to Test Ultra-Sensitive Blood-Based Assay for Early-Stage Lung Cancer Recurrence RiskA Fox Chase Cancer Center study will evaluate a tumor-informed, whole-genome sequencing–based test to assess recurrence risk in early-stage NSCLC.onclive · 3mo ago↗ source
- FDA Grants Breakthrough Therapy Designation to Emi-Le for Adenoid Cystic CarcinomaEmi-Le received breakthrough therapy designation from the FDA for the treatment of patients with locally advanced, recurrent or metastatic ACC.